Met Life Investment Management, LLC Atea Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 45,200 shares of AVIR stock, worth $147,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,200
Previous 45,200
-0.0%
Holding current value
$147,804
Previous $149,000
1.34%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
52.4MCall Options Held
900Put Options Held
126K-
Black Rock Inc. New York, NY9.12MShares$29.8 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN6.65MShares$21.7 Million13.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$17.8 Million0.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$15.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.61MShares$15.1 Million1.31% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $272M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...